Protagonist Therapeutics Inc (NASDAQ:PTGX)
| 24.29 Delayed Data As of Jan 15 |  +1.44 / +6.30%Today’s Change | 5.30 Today|||52-Week Range 25.65 | +20.49% Year-to-Date |
Latest PTGX News | Press Releases
No recent news for Protagonist Therapeutics Inc.
Today’s Trading
| Previous close | 22.85 |
| Today’s open | 21.71 |
| Day’s range | 23.35 - 24.62 |
| Volume | 22,499 |
| Average volume (3 months) | 450,893 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -71.28% |
| Earnings growth (this year) | +35.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -99.25% |
| P/E ratio | NM |
| Price/Sales | 790.27 |
| Price/Book | 8.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RDUSRadius Health Inc | -0.85 | -3.77% |
| CRISCuris Inc | +1.02 | +8.65% |
| CGENCompugen Ltd | -0.47 | -3.48% |
| CRTXCortexyme Inc | +0.59 | +1.85% |
Data as of 5:23pm ET, 01/15/2021
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $231.0K |
| Annual profit (last year) | -$77.2M |
| Net profit margin | -33,414.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
